SM
DMK

Sabby Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Sabby Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5
Closed -$19K – 200
2021
Q4 		$19K Sell
5
-26
-84% -$1.62K ﹤0.01% 183
2021
Q3 		$210K Buy
+31
New +$2.27K 0.03% 142

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management's DMK Position: Q2 2020 in Review

Sabby Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2020, closing a stake of 1,260 shares — an estimated $32K sold.

Sabby Management first reported a position in DMK in Q4 2013 and held it in 5 quarters. The position peaked at $2.6M in Q4 2013. 47 funds tracked by Wall St. Rank hold DMK as of Q2 2020.

  • Sabby Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2020 after selling out during the quarter.
  • Sabby Management sold 1,260 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2020, an estimated $32K.
  • Sabby Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2013 and held it in 5 quarters.
  • Sabby Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $2.6M in Q4 2013.
  • 47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2020.

Based on Sabby Management's 13F filing for Q2 2020, filed 14 Aug 2020.